The Effective Factors on The Sexual Function of Polycystic Ovary Syndrome Women: A Cross-Sectional Study

Document Type : Original Article


1 Midwife in Social Security Organization, Hamadan Branch, Hamadan, Iran

2 Autism Spectrum Disorders Research Center, Hamadan University of Medical Sciences, Hamadan, Iran

3 Department of Epidemiology, Hamadan University of Medical Sciences, Hamadan, Iran

4 Department of Nursing and Midwifery, Hamadan University of Medical Sciences, Hamadan, Iran


Background: One of the most common endocrine disorders in women during reproductive age is polycystic ovary
syndrome (PCOS). This study aimed to evaluate sexual functioning among women with PCOS in a sample of a region’s
population in the west of Iran.
Materials and Methods: This study was a cross-sectional study that was conducted on 130 women with PCOS who
referred to three clinics of gynecology, infertility, and dermatology affiliated with Hamadan University of Medical
Sciences, Iran, from September to November 2020. The measurement tools included demographic characteristics,
hirsutism score, and sexual function was assessed using the female sexual function index (FSFI) questionnaire.
Results: In total, 60% of patients had reported sexual dysfunction related to lubrication, satisfaction, and pain as domains
of sexual dysfunction. The number 109 (83.85%) of them had hirsutism and these patients had a lower score for
lubrication (3.7 ± 1.47 vs. 4.47 ± 1.71, P=0.03), orgasm (3.2 ± 1.34 vs. 3.95 ± 1.37, P=0.02), satisfaction (3.4 ± 1.29
vs. 3.71 ± 1.33, P=0.03), and FSFI score (22.56 ± 5.78 vs. 25.42 ± 5.51, P=0.04). Women with higher education had
reported higher scores of FSFI and its domains. Rural participants had a higher arousal score (3.93 ± 1.4 vs. 3.37 ±
1.28, P=0.04). Moreover, housekeeper women had higher scores regarding desire, pain, and total FSFI score.
Conclusion: Our results showed that there was a significant association between hirsutism and FSFI scores, different
domains, including lubrication, orgasm, and satisfaction.


  1. Williamson K, Gunn AJ, Johnson N, Milsom SR. The impact of ethnicity on the presentation of polycystic ovarian syndrome. Aust N Z J Obstet Gynaecol. 2001; 41(2): 202-206.
  2. Bani Mohammad M, Majdi Seghinsara A. Polycystic ovary syndrome (PCOS), diagnostic criteria, and AMH. Asian Pac J Cancer Prev. 2017; 18(1): 17-21.
  3. Faghfoori Z, Fazelian S, Shadnoush M, Goodarzi R. Nutritional management in women with polycystic ovary syndrome: a review study. Diabetes Metab Syndr. 2017; 11 Suppl 1: S429-S432.
  4. Amiri M, Bidhendi Yarandi R, Nahidi F, Tohidi M, Ramezani Tehrani F. The relationship between clinical and biochemical characteristics and quality of life in patients with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2019; 90(1): 129-137.
  5. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81(1): 19-25.
  6. Gombert M, Ballester P, Segura A, Peiró AM. Introducing sexual dysfunction in mental care. Expert Opin Drug Saf. 2021; 20(1): 69- 79.
  7. Nasiri Amiri F, Ramezani Tehrani F, Esmailzadeh S, Tohidi M, Azizi F, Basirat Z. Sexual function in women with polycystic ovary syndrome and their hormonal and clinical correlations. Int J Impot Res. 2018; 30(2): 54-61.
  8. Dashti S, Latiff LA, Hamid HA, Sani SM, Akhtari-Zavare M, Abu Bakar AS, et al. Sexual dysfunction in patients with polycystic ovary syndrome in malaysia. Asian Pac J Cancer Prev. 2016; 17(8): 3747-3751.
  9. Eftekhar T, Sohrabvand F, Zabandan N, Shariat M, Haghollahi F, Ghahghaei-Nezamabadi A. Sexual dysfunction in patients with polycystic ovary syndrome and its affected domains. Iran J Reprod Med. 2014; 12(8): 539-546.
  10. Lumezi BG, Berisha VL, Pupovci HL, Goçi A, Hajrushi AB. Grading of hirsutism based on the Ferriman-Gallwey scoring system in Kosovar women. Postepy Dermatol Alergol. 2018; 35(6): 631-635.
  11. Atis G, Dalkilinc A, Altuntas Y, Atis A, Gurbuz C, Ofluoglu Y, et al. Hyperthyroidism: a risk factor for female sexual dysfunction. J Sex Med. 2011; 8(8): 2327-2333.
  12. Lombardi G, Celso M, Bartelli M, Cilotti A, Del Popolo G. Female sexual dysfunction and hormonal status in multiple sclerosis patients. J Sex Med. 2011; 8(4): 1138-1146.
  13. Mohammadi KH, Heidari M, Faghihzadeh S. The female sexual function index (FSFI): validation of the Iranian version. Payesh. 2008; 7(3): 269-278.
  14. Khademi A, Alleyassin A, Amini M, Ghaemi M. Evaluation of sexual dysfunction prevalence in infertile couples. J Sex Med. 2008; 5(6): 1402-1410.
  15. Singh JC, Tharyan P, Kekre NS, Singh G, Gopalakrishnan G. Prevalence and risk factors for female sexual dysfunction in women attending a medical clinic in south India. J Postgrad Med. 2009; 55(2): 113-120.
  16. Kogure GS, Ribeiro VB, Lopes IP, Furtado CLM, Kodato S, Silva de Sá MF, et al. Body image and its relationships with sexual functioning, anxiety, and depression in women with polycystic ovary syndrome. J Affect Disord. 2019; 253: 385-393.
  17. Ferraresi SR, Lara LA, Reis RM, Rosa e Silva AC. Changes in sexual function among women with polycystic ovary syndrome: a pilot study. J Sex Med. 2013; 10(2): 467-473.
  18. Firmino Murgel AC, Santos Simões R, Maciel GAR, Soares JM -Jr, Baracat EC. Sexual dysfunction in women wth polycystic ovary syndrome: systematic review and meta-analysis. J Sex Med. 2019; 16(4): 542-550